The array of chemical compounds known to enhance CYP3A7-CYP3AP1 activity demonstrates the complex regulation of this protein, primarily mediated through the activation of nuclear receptors like PXR and CAR. Rifampicin stands out as a potent inducer of CYP3A enzymes, including CYP3A7-CYP3AP1, by binding to and activating PXR, which subsequently upregulates the transcription of genes encoding these enzymes. Similarly, Phenobarbital and Carbamazepine, through their activation of CAR and PXR respectively, also enhance the expression of CYP3A7-CYP3AP1. The induction of CYP3A enzymes by Dexamethasone, via glucocorticoid receptor-mediated pathways, further illustrates the diverse mechanisms through which CYP3A7-CYP3AP1 activity can be augmented.
Hypericin, activates PXR, leading to an increase in CYP3A enzyme levels, including CYP3A7-CYP3AP1. Interestingly, Erythromycin, while primarily an inhibitor of CYP3A enzymes, can paradoxically induce these enzymes, including CYP3A7-CYP3AP1, particularly with prolonged usage. The thiazolidinediones, Troglitazone and Pioglitazone, both act as PXR activators, inducing CYP3A enzymes and hence potentially enhancing CYP3A7-CYP3AP1 activity. Ritonavir, commonly known as a CYP inhibitor, can exhibit inducing effects on CYP3A enzymes at low concentrations or during chronic administration. Clotrimazole's activation of PXR and the consequent induction of CYP3A enzymes, Nifedipine's similar effect likely via PXR, and Omeprazole's potential induction through PXR or other nuclear receptors, all contribute to the enhanced activity of CYP3A7-CYP3AP1. This multifaceted regulation underscores the intricate network of signaling and transcriptional control that governs the activity of CYP3A7-CYP3AP1, reflecting its critical role in various physiological processes. The interplay of these activators, through their specific actions on nuclear receptors and signaling pathways, emphasizes the complexity of pharmacogenomic interactions and the importance of understanding the molecular mechanisms underpinning the regulation of key metabolic enzymes like CYP3A7-CYP3AP1. These activators, by modulating the expression and activity of CYP3A7-CYP3AP1, highlight the protein's pivotal role in responding to various xenobiotics and endogenous compounds.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
Binds to PXR, leading to transcriptional activation of genes for CYP3A enzymes, potentially enhancing CYP3A7-CYP3AP1 activity. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Induces CYP3A enzyme expression through glucocorticoid receptor-mediated pathways, potentially enhancing CYP3A7-CYP3AP1 activity. | ||||||
Carbamazepine | 298-46-4 | sc-202518 sc-202518A | 1 g 5 g | $32.00 $70.00 | 5 | |
Induces CYP3A enzyme expression via PXR receptor, potentially increasing CYP3A7-CYP3AP1 activity. | ||||||
Hypericin | 548-04-9 | sc-3530 sc-3530A | 1 mg 5 mg | $65.00 $210.00 | 11 | |
Induces CYP3A enzymes through PXR activation, enhancing CYP3A7-CYP3AP1 activity. | ||||||
Erythromycin | 114-07-8 | sc-204742 sc-204742A sc-204742B sc-204742C | 5 g 25 g 100 g 1 kg | $56.00 $240.00 $815.00 $1305.00 | 4 | |
Can induce CYP3A enzymes, including CYP3A7-CYP3AP1, particularly with prolonged use. | ||||||
Troglitazone | 97322-87-7 | sc-200904 sc-200904B sc-200904A | 5 mg 10 mg 25 mg | $108.00 $200.00 $426.00 | 9 | |
Activates PXR, leading to the induction of CYP3A enzymes, including CYP3A7-CYP3AP1. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $54.00 $123.00 | 13 | |
Activates PXR, inducing the expression of CYP3A enzymes, potentially enhancing CYP3A7-CYP3AP1 activity. | ||||||
Ritonavir | 155213-67-5 | sc-208310 | 10 mg | $122.00 | 7 | |
Known as a CYP inhibitor but can also induce CYP3A enzymes, including CYP3A7-CYP3AP1, at low concentrations or with chronic administration. | ||||||
Clotrimazole | 23593-75-1 | sc-3583 sc-3583A | 100 mg 1 g | $41.00 $56.00 | 6 | |
Induces CYP3A enzymes by activating the PXR receptor, potentially leading to increased CYP3A7-CYP3AP1 activity. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
Induces CYP3A enzymes, likely mediated through PXR receptor, potentially enhancing CYP3A7-CYP3AP1 activity. | ||||||